Examining ccRCC transcriptome data, we discovered that the DEGs between high- and low-CHEK2 expression groups were significantly enriched in linolenic acid and arachidonic acid metabolism pathways. The gene discussed is CHEK2; the disease is nonpapillary renal cell carcinoma.